Tomonari Shinozaki1, Toshihiko Yamada1, Takahiro Nonaka1, Tatsuo Yamamoto2. 1. Department of Anesthesiology, School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto-shi, Kumamoto, 860-8556, Japan. 2. Department of Anesthesiology, School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto-shi, Kumamoto, 860-8556, Japan. yamyam@kumamoto-u.ac.jp.
Abstract
PURPOSE: Although non-steroidal anti-inflammatory drugs and acetaminophen have no proven efficacy against neuropathic pain, they are frequently prescribed for neuropathic pain patients. We examined whether the combination of opioids (tramadol and morphine) with indomethacin or acetaminophen produce favorable effects on neuropathic pain and compared the efficacy for neuropathic pain with that for inflammatory pain. METHODS: The carrageenan model was used as the inflammatory pain model while the tibial neuroma transposition (TNT) model was used as the neuropathic pain model. The tibial nerve is transected in the TNT model, with the tibial nerve stump then transpositioned to the lateral aspect of the hindlimb. Neuropathic pain (mechanical allodynia and neuroma pain) is observed after TNT injury. Drugs were administered orally. RESULTS: In the carrageenan model, all drugs produced anti-allodynic effects and all drug combinations, but not tramadol + indomethacin combination, produced synergistic anti-allodynic effects. In the TNT model, tramadol and morphine, but not acetaminophen and indomethacin, produced anti-neuropathic pain effects. In the combination, with the exception of morphine + acetaminophen combination, both acetaminophen and indomethacin reduced the 50% effective dose (ED50) of tramadol and morphine as compared with the ED50s for the single drug study in the TNT model. The ED50s of tramadol and morphine in the carrageenan combination test were not statistically significantly different from the ED50s in the TNT model combination study. CONCLUSIONS: The combination of opioids with indomethacin or acetaminophen produced a synergistic analgesic effect both in inflammatory and neuropathic pain with some exceptions. The efficacy of these combinations for neuropathic pain was not different from that for inflammatory pain.
PURPOSE: Although non-steroidal anti-inflammatory drugs and acetaminophen have no proven efficacy against neuropathic pain, they are frequently prescribed for neuropathic painpatients. We examined whether the combination of opioids (tramadol and morphine) with indomethacin or acetaminophen produce favorable effects on neuropathic pain and compared the efficacy for neuropathic pain with that for inflammatory pain. METHODS: The carrageenan model was used as the inflammatory pain model while the tibial neuroma transposition (TNT) model was used as the neuropathic pain model. The tibial nerve is transected in the TNT model, with the tibial nerve stump then transpositioned to the lateral aspect of the hindlimb. Neuropathic pain (mechanical allodynia and neuroma pain) is observed after TNT injury. Drugs were administered orally. RESULTS: In the carrageenan model, all drugs produced anti-allodynic effects and all drug combinations, but not tramadol + indomethacin combination, produced synergistic anti-allodynic effects. In the TNT model, tramadol and morphine, but not acetaminophen and indomethacin, produced anti-neuropathic pain effects. In the combination, with the exception of morphine + acetaminophen combination, both acetaminophen and indomethacin reduced the 50% effective dose (ED50) of tramadol and morphine as compared with the ED50s for the single drug study in the TNT model. The ED50s of tramadol and morphine in the carrageenan combination test were not statistically significantly different from the ED50s in the TNT model combination study. CONCLUSIONS: The combination of opioids with indomethacin or acetaminophen produced a synergistic analgesic effect both in inflammatory and neuropathic pain with some exceptions. The efficacy of these combinations for neuropathic pain was not different from that for inflammatory pain.
Authors: Edward D Högestätt; Bo A G Jönsson; Anna Ermund; David A Andersson; Henrik Björk; Jessica P Alexander; Benjamin F Cravatt; Allan I Basbaum; Peter M Zygmunt Journal: J Biol Chem Date: 2005-06-29 Impact factor: 5.157
Authors: Christophe Mallet; David A Barrière; Anna Ermund; Bo A G Jönsson; Alain Eschalier; Peter M Zygmunt; Edward D Högestätt Journal: PLoS One Date: 2010-09-17 Impact factor: 3.240
Authors: Joseph V Pergolizzi; Mart van de Laar; Richard Langford; Hans-Ulrich Mellinghoff; Ignacio Morón Merchante; Srinivas Nalamachu; Joanne O'Brien; Serge Perrot; Robert B Raffa Journal: J Pain Res Date: 2012-08-29 Impact factor: 3.133
Authors: Fangyu Du; Ruolin Cao; Lu Chen; Jianwen Sun; Yajie Shi; Yang Fu; Bruce D Hammock; Zhonghui Zheng; Zhongbo Liu; Guoliang Chen Journal: Acta Pharm Sin B Date: 2021-09-22 Impact factor: 14.903